Mutations in the GARS protein — found in people with Charcot-Marie-Tooth disease type 2D…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new vaccines and medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
Scientists in China examined the relationship between genetic mutations in the MORC2 gene and the various disease characteristics…
A small study described variable clinical and MRI findings in three Korean people with rare dominant intermediate…
A form of gene therapy that reduces levels of the PMP22 protein prevented the development of…
Children and teenagers with Charcot-Marie-Tooth (CMT) disease have until May 15 to…
Sciatic motor nerves in mice lacking the GJB1 gene — defective in people with…
A large multicenter study on the natural history of Charcot-Marie-Tooth disease type 2A…
Treating a woman with Charcot-Marie-Tooth disease type 2 (CMT2) with an…
A common pathway malfunction was found to underlie Charcot–Marie–Tooth (CMT) disease subtypes 1C…
Blocking a protein called CMTM6 in myelin-producing cells increases the thickness of nerve fibers and the speed at which…